These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 15811481

  • 1. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers.
    Cryer B, Berlin RG, Cooper SA, Hsu C, Wason S.
    Clin Ther; 2005 Feb; 27(2):185-91. PubMed ID: 15811481
    [Abstract] [Full Text] [Related]

  • 2. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE, Gottesdiener K, Huntington M, Wong P, Larson P, Wildonger L, Gillen L, Dorval E, Waldman SA.
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [Abstract] [Full Text] [Related]

  • 3. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
    Schiff M, Hochberg MC, Oldenhof J, Brune K.
    Curr Med Res Opin; 2009 Oct; 25(10):2471-7. PubMed ID: 19678751
    [Abstract] [Full Text] [Related]

  • 4. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ, Hwang C, Datto C, Desai B, Sostek M.
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [Abstract] [Full Text] [Related]

  • 5. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P.
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [Abstract] [Full Text] [Related]

  • 6. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB.
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [Abstract] [Full Text] [Related]

  • 7. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R, Krishnaswami S, Kowalski K.
    Clin Ther; 2007 Apr; 29 Suppl():2498-510. PubMed ID: 18164917
    [Abstract] [Full Text] [Related]

  • 8. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
    Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V.
    J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
    [Abstract] [Full Text] [Related]

  • 9. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
    Fiorucci S, Santucci L, Gresele P, Faccino RM, Del Soldato P, Morelli A.
    Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
    [Abstract] [Full Text] [Related]

  • 10. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
    Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VZ, Voelker M.
    Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
    [Abstract] [Full Text] [Related]

  • 11. Effects of ibuprofen on sleep quality as measured using polysomnography and subjective measures in healthy adults.
    Gengo F.
    Clin Ther; 2006 Nov; 28(11):1820-6. PubMed ID: 17213002
    [Abstract] [Full Text] [Related]

  • 12. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM, Hennekens CH, Tofler GH, Lipinska I, Buring JE.
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [Abstract] [Full Text] [Related]

  • 13. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers.
    Wilner KD, Rushing M, Walden C, Adler R, Eskra J, Noveck R, Vargas R.
    J Clin Pharmacol; 2002 Sep; 42(9):1027-30. PubMed ID: 12211219
    [Abstract] [Full Text] [Related]

  • 14. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
    Mathieu P, Villemot JP, Stoltz JF, Scheck F, Garnier LF.
    Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 17. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
    Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB.
    Headache; 2006 Mar; 46(3):444-53. PubMed ID: 16618262
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial.
    Tang YD, Rinder HM, Katz SD.
    Am Heart J; 2007 Sep; 154(3):494.e1-7. PubMed ID: 17719296
    [Abstract] [Full Text] [Related]

  • 19. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC, Fiske K, Lyne A.
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [Abstract] [Full Text] [Related]

  • 20. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.